Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer
- 16 December 2010
- journal article
- review article
- Published by Elsevier BV in Urologic Oncology: Seminars and Original Investigations
- Vol. 30 (4), 369-378
- https://doi.org/10.1016/j.urolonc.2010.08.007
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Effects of Denosumab on Bone Mineral Density in Men Receiving Androgen Deprivation Therapy for Prostate CancerJournal of Urology, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerNew England Journal of Medicine, 2009
- Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II TrialJournal of Urology, 2009
- Randomized Phase II Trial of Denosumab in Patients With Bone Metastases From Prostate Cancer, Breast Cancer, or Other Neoplasms After Intravenous BisphosphonatesJournal of Clinical Oncology, 2009
- Change in Markers of Bone Metabolism with Chemotherapy for Advanced Prostate Cancer: Interleukin-6 Response Is a Potential Early Indicator of Response to TherapyJournal of Interferon & Cytokine Research, 2009
- Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of menClinical Endocrinology, 2008
- Skeletal Health After Continuation, Withdrawal, or Delay of Alendronate in Men With Prostate Cancer Undergoing Androgen-Deprivation TherapyJournal of Clinical Oncology, 2008
- Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acidCancer, 2008
- Predictors of Skeletal Complications in Men with Hormone-Refractory Metastatic Prostate CancerUrology, 2007
- Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate CancerJournal of Clinical Oncology, 2007